Logo

ANTHEM BIOSCIENCES LTD Share Price

NSE: ANTHEM
|
Pharmaceuticals
₹ 770.90
-₹1.45 (-0.19%)
1D
Last updated 03 Jul, 2026, 15:53 IST

ANTHEM BIOSCIENCES LTD Share Price Today

As of 5 Jul 2026, ANTHEM BIOSCIENCES LTD share price is ₹770.90. The stock opened at ₹779.00, compared to its previous close of ₹772.35. During today's trading session, ANTHEM BIOSCIENCES LTD share price moved in the range of ₹766.50 to ₹779.70, with an average price of ₹773.10 for the day. Looking at its last 52-week, the stock has touched a low of ₹579.15 and a high of ₹873.50. On the performance front, ANTHEM BIOSCIENCES LTD share price has increased by 17.79% over the last six months and is up 5.55% on a year-on-year basis.

₹766.50
0.19% down today
₹779.70
1D LOW
1D HIGH

ANTHEM BIOSCIENCES LTD Returns Calculator

Open
₹779.00
High
₹779.70
Low
₹766.50
Prev. close
₹772.35
Circuit
L
H
₹616.75
₹925.05
52-week
L
H
₹579.15
₹873.50

ANTHEM BIOSCIENCES LTD Shareholder Returns

ANTHEM BIOSCIENCES LTD Share Price History

Mkt Cap Cr
43,439.20
P/E
73.39
P/B
14.28
ROE
19.45%
D/E
0.02
ROCE
26.70%
Div. Yield
0.26%
EPS(TTM)
11.95
Turnover
0.64
EV/EBITDA
44.30
Net Margin
0.00%
Op. Margin
0.00%
ROA
17.26%
Quick Ratio
0.00
Curr. Ratio
6.38
Based on fundamentals, this stock's
Step 2 of 5
Performance
Poor
Anthem Bioscienc has underperformed the market
Step 1 of 5
Valuation
Overvalued
Anthem Bioscienc appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Anthem Bioscienc revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

ANTHEM BIOSCIENCES LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,844.55₹1,419.37₹1,056.92₹1,231.26
Other Income₹85.73₹63.70₹77.07₹48.98
Total Revenue₹1,930.29₹1,483.07₹1,133.99₹1,280.24
Total Expenses₹1,273.42₹1,005.75₹698.50₹734.10
Profit Before Tax₹656.87₹477.32₹497.30₹546.14
Tax₹205.61₹110.01₹112.11₹140.60
Profit After Tax₹451.26₹367.31₹385.19₹405.54
EPS - Basic₹8.07₹6.48₹6.75₹467.55
EPS - Diluted₹8.04₹6.48₹6.75₹467.53

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹656.87₹477.32₹497.30₹546.14
Income before WC changes₹729.71₹522.15₹524.62₹594.00
Change in Assets-₹172.83-₹338.56-₹36.41-₹108.27
Change in Liabilities₹20.46₹76.56-₹67.22-₹29.82
Change in WC-₹152.37-₹262.00-₹103.63-₹138.08
Cash flow from Operations₹418.34₹140.15₹305.99₹332.91
Cash flow from Investing-₹152.11-₹221.46-₹376.02-₹205.45
Cash flow from Financing-₹133.60-₹77.18₹63.97₹180.68
Total Cash Flow₹132.62-₹158.49-₹6.06₹308.14
Cash (Start of the year)₹184.36₹342.85₹348.90₹40.77
Cash (End of the year)₹316.98₹184.36₹342.85₹348.90

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,070.87₹916.56₹691.29₹521.15
Current Assets₹1,736.72₹1,481.56₹1,323.17₹1,097.71
Total Assets₹2,807.58₹2,398.11₹2,014.46₹1,618.87
Current Liabilities₹326.23₹338.63₹163.87₹223.21
Net Current Asset₹1,410.49₹1,142.93₹1,159.30₹874.51
Non-Current Liabilities₹71.49₹134.83₹109.92₹40.66
Equity Capital₹2,409.86₹1,924.65₹1,740.67₹1,355.00
Total Equity & Liabilities₹2,807.58₹2,398.11₹2,014.46₹1,618.87

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,840.65₹1,417.54₹1,056.92₹1,231.26
Other Income₹109.44₹70.52₹77.37₹48.98
Total Revenue₹1,950.09₹1,488.06₹1,134.30₹1,280.24
Total Expenses₹1,238.67₹1,003.29₹698.32₹733.64
Profit Before Tax₹711.42₹484.77₹497.78₹546.59
Tax₹205.24₹109.99₹112.11₹140.60
Profit After Tax₹506.19₹374.78₹385.67₹405.99
EPS - Basic₹9.05₹6.61₹6.76₹462.98
EPS - Diluted₹9.01₹6.61₹6.76₹462.95

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹711.42₹484.77₹497.78₹546.59
Income before WC changes₹747.48₹521.94₹524.69₹594.45
Change in Assets-₹150.48-₹308.98-₹12.39-₹108.23
Change in Liabilities₹1.84₹71.44-₹78.32-₹29.87
Change in WC-₹148.64-₹237.54-₹90.71-₹138.10
Cash flow from Operations₹439.84₹164.41₹318.98₹333.35
Cash flow from Investing-₹246.31-₹191.76-₹377.91-₹205.78
Cash flow from Financing-₹66.42-₹131.59₹52.85₹180.68
Total Cash Flow₹127.10-₹158.95-₹6.07₹308.24
Cash (Start of the year)₹183.85₹342.79₹348.87₹40.62
Cash (End of the year)₹310.95₹183.85₹342.79₹348.87

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,171.49₹878.74₹673.39₹522.10
Current Assets₹1,664.07₹1,445.49₹1,319.62₹1,097.08
Total Assets₹2,835.56₹2,324.23₹1,993.02₹1,619.18
Current Liabilities₹291.18₹302.26₹152.61₹223.05
Net Current Asset₹1,372.89₹1,143.23₹1,167.01₹874.03
Non-Current Liabilities₹71.18₹88.89₹98.79₹40.66
Equity Capital₹2,473.21₹1,933.07₹1,741.62₹1,355.46
Total Equity & Liabilities₹2,835.56₹2,324.23₹1,993.02₹1,619.18
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
770.9
595
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 595
Buy orders: 0%
Sell orders: 100%
Bearish
0
Neutral
6
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
50.39
Neutral
ATR (14)
21.94
Neutral
STOCH(9,6)
39.9
Neutral
STOCH RSI (14)
24.2
Neutral
ADX(9)
10.58
Bullish
UO(9)
39.67
Neutral
ROC(12)
0.16
Bullish
WillR(14)
-73.53
Neutral
Period
Simple value
Exponential vaue
5D
770.38
770.22
10D
771.59
771.08
20D
773.61
771.24
50D
772.19
759.5
100D
724.79
736.19

About ANTHEM BIOSCIENCES LTD

ANTHEM BIOSCIENCES LTD logo
ISIN
INE0CZ201020
Sector Market Cap
₹ 43,439.2 Cr

Anthem Biosciences Limited is an India-based contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. The Company helps new and established biotech’s and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and much more. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its product line includes human nutrition, animal health, and industrial products. Under human nutrition, it offers active pharmaceutical ingredients, dietary supplements, probiotics, and enzymes, among others.

ANTHEM BIOSCIENCES LTD Financial Highlights

  • Revenue: ANTHEM BIOSCIENCES LTD reported revenue of ₹2,280.11 crore in FY26 vs ₹1,930.28 crore in FY25. It showed an increase of 18.12% on a yearly basis.
  • Operating Profit: ANTHEM BIOSCIENCES LTD reported an operating profit of ₹824.24 crore in FY26 vs ₹656.87 crore in FY25. It showed an increase of 25.48% on a year-on-year basis.
  • Net Profit: ANTHEM BIOSCIENCES LTD reported a net profit of ₹591.79 crore in FY26 vs ₹451.26 crore in FY25. It showed an increase of 31.14% on a yearly basis.

ANTHEM BIOSCIENCES LTD Quarterly Result Highlights

  • ANTHEM BIOSCIENCES LTD reported revenue of ₹662.15 crore in Mar 2026, compared with ₹456.68 crore in Dec 2025, representing an increase of 44.99% on a quarter-on-quarter (QoQ) basis.
  • ANTHEM BIOSCIENCES LTD reported an operating profit of ₹277.92 crore in Mar 2026, compared with ₹130.47 crore in Dec 2025, representing an increase of 113.01% on a quarter-on-quarter (QoQ) basis.
  • ANTHEM BIOSCIENCES LTD reported a profit of ₹189.76 crore in Mar 2026, compared with ₹92.82 crore in Dec 2025, reflecting an increase of 104.44% on a QoQ basis.
  • The earnings per share (EPS) of ANTHEM BIOSCIENCES LTD stood at ₹8.07 during Mar 2026.
Know more
Promoters
74.68%
FII
1.28%
Other DII
1.42%
Retail and other
12.50%
Mutual funds
10.12%
Foreign institutions - FII
Compare against other stocks
ANTHEM BIOSCIENCES LTD logo
ANTHEM BIOSCIENCES LTD
Pharmaceuticals
Add Stock
Add Another

FAQs on ANTHEM BIOSCIENCES LTD Share Price